Youtor
Can Novo Nordisk bounce back
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=nsKtyT3v5tU
Shares in Novo Nordisk fell as much as 15 per cent after the US Food and Drug Administration withheld approval for its new insulin treatment pending further tests. With a quick approval previously priced into its stock, the decision came as a shock to the company. Lex's Julia Grindell and Vincent Boland consider whether the group's shares are now fairly priced, and the impact of the decision on this year's earnings. • Related Articles: • http://www.ft.com/intl/cms/s/0/4e55f5... • http://www.ft.com/intl/cms/s/3/5fd083... • For more video content from the Financial Times, visit http://www.FT.com/video
#############################
